INTEGRATED CORE STRATEGIES (US) LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Pyxis Oncology, Inc. Common Stock, par value $0.001 per share (PYXS)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Pyxis Oncology, Inc. Common Stock, par value $0.001 per share
Symbol
PYXS
Shares outstanding
62,201,975 shares
Disclosed Ownership
2,488,079 shares
Ownership
4%
Form type
SCHEDULE 13G/A
Filing time
06 May 2025, 16:17:33 UTC
Date of event
31 Mar 2025
Previous filing
16 Dec 2024
SEC
View on sec.gov

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 4% ownership in Pyxis Oncology, Inc. Common Stock, par value $0.001 per share (PYXS) on 31 Mar 2025."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Pyxis Oncology, Inc. Common Stock, par value $0.001 per share (PYXS).
  • Disclosed ownership: 4%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 16 Dec 2024.
  • Current filing was accepted on 06 May 2025, 16:17.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 4% 2,484,992 0 2,484,992 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 4% 2,488,079 0 2,488,079 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 4% 2,488,079 0 2,488,079 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 4% 2,488,079 0 2,488,079 /s/ Israel A. Englander Israel A. Englander